health
FDA Approves First Treatment for Rare MCT8 Deficiency, Allan-Herndon-Dudley Syndrome

The US Food and Drug Administration (FDA) has approved tiratricol (Emcitate) for treating peripheral thyrotoxicosis in adults and children with monocarboxylate transporter 8 (MCT8) deficiency, also...
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories

AI shifts healthcare focus towards predicting future disease risks
Magzter

Hyderabad’s cholesterol, sugar woes meet Bengaluru’s vitamin deficiency problem
The South First

JMIR Publications’ JMIR Cardio Invites Submissions on Generative and Multimodal AI in Digital Cardiovascular Medicine
Newswise

Do You Bring Your Shoes Inside The House? It Might Be Silently Risking Your Health
Onlymyhealth

What Is The Statistical Probability Test That Flagged Cheating In KPSC Exam And How Does It Work?
News 18